BioSpace News Archive

Pluristem’s PLX Cells Significantly Inhibit Cancer Cell Growth in Newly Published Study

Data from the first study showed that the modified PLX cells exhibited an anti-proliferative effect on 45% of the tested cancer cell lines.

January 12, 2018
·
6 min read
Biotech Bay

Kalytera Announces Settlement of Debt Transaction

The debt owing is in the amount of US$76,000 (or C$94,969.60 based on the daily average exchange rate for January 10, 2018 published by the Bank of Canada).

January 12, 2018
·
3 min read
Biotech Beach

Dovetail Genomics Unveils New Dovetail Hi-C Kit

Dovetail Genomics today expanded its commitment to the research world to make best-in-class genome assemblies available to all.

January 12, 2018
·
2 min read
Business

OPKO’S GeneDx Announces Research Collaboration With Radboud University Medical Center

The deal is aimed at identifying novel genes and pathways to help manage human genetic diseases.

January 12, 2018
·
5 min read
Lone Star Bio

Rice University Release: Fed Grant Will Help Unlock Embryonic Secrets

The work will build upon Warmflash’s research into human embryonic development and the mechanisms by which nearly identical cells morph over time into the hundreds of types that become a mature organism.

January 12, 2018
·
4 min read
BioMidwest

Fresenius Kabi Introduces Bortezomib for Injection

Fresenius Kabi announced today the availability in the United States of Bortezomib for Injection

January 12, 2018
·
3 min read
Policy

Statement From FDA Commissioner Scott Gottlieb, M.D., on FDA Decision to Seek Additional Time to Reassess Rule That Would Have Changed Longstanding Practices for How the Agency Determined the ‘Intended Use’ of Medical Products

The FDA is committed to ensuring that we have the right policies and processes in place to fulfill our public health mission.

January 12, 2018
·
3 min read
FDA

Myriad Wins FDA OK for BRACAnalysis CDx as Companion Diagnostic for Lynparza (olaparib) in Patients With Metastatic Breast Cancer

BRACAnalysis CDx is the first and only FDA-approved test for use in this indication.

January 12, 2018
·
9 min read
FDA

FDA Green Lights AstraZeneca, Merck’s Lynparza for Metastatic Breast Cancer

Lynparza is the first and only PARP inhibitor approved for use beyond ovarian cancer.

January 12, 2018
·
19 min read
Business

Primetime Announces a CRADA With NIST to Characterize a Potentially New Class of Antimicrobials

Under this agreement, Primetime will collaborate with Dr. Prasad Reddy who is a recognized expert in chorismate mutase enzymology.

January 12, 2018
·
1 min read